Synthesis, in-vitro cholinesterase inhibition, in-vivo anticonvulsant activity and in-silico exploration of N-(4-methylpyridin-2-yl)thiophene-2-carboxamide analogs.

[1]  F. A. Khan,et al.  Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors. , 2019, Bioorganic chemistry.

[2]  Brivaracetam , 2018, Reactions Weekly.

[3]  U. Rashid,et al.  Design, synthesis, in-vitro thymidine phosphorylase inhibition, in-vivo antiangiogenic and in-silico studies of C-6 substituted dihydropyrimidines. , 2018, Bioorganic chemistry.

[4]  S. Khan,et al.  Facile synthesis of N- (4-bromophenyl)-1- (3-bromothiophen-2-yl)methanimine derivatives via Suzuki cross-coupling reaction: their characterization and DFT studies , 2018, Chemistry Central Journal.

[5]  E. Ritzl,et al.  Antiepileptic drugs in critically ill patients , 2018, Critical Care.

[6]  F. Nasim,et al.  Palladium(0) catalyzed Suzuki cross-coupling reaction of 2,5-dibromo-3-methylthiophene: selectivity, characterization, DFT studies and their biological evaluations , 2018, Chemistry Central Journal.

[7]  Masud Husain,et al.  Cognition and dementia in older patients with epilepsy , 2018, Brain : a journal of neurology.

[8]  Dae Ki Hong,et al.  Diverse Effects of an Acetylcholinesterase Inhibitor, Donepezil, on Hippocampal Neuronal Death after Pilocarpine-Induced Seizure , 2017, International journal of molecular sciences.

[9]  G. Zaccara,et al.  Treatment of epilepsy in patients with Alzheimer’s disease , 2017, Expert review of neurotherapeutics.

[10]  M. Manford,et al.  Recent advances in epilepsy , 2017, Journal of Neurology.

[11]  U. Rashid,et al.  Rational design and synthesis of dihydropyrimidine based dual binding site acetylcholinesterase inhibitors. , 2016, Bioorganic chemistry.

[12]  F. Raudino.  Alzheimers’ Disease and Epilepsy: A Literature Review , 2016 .

[13]  Mohammad Tuhin Ali,et al.  Halogen-directed drug design for Alzheimer’s disease: a combined density functional and molecular docking study , 2016, SpringerPlus.

[14]  Usman Ali Rana,et al.  Efficient Double Suzuki Cross-Coupling Reactions of 2,5-Dibromo-3-hexylthiophene: Anti-Tumor, Haemolytic, Anti-Thrombolytic and Biofilm Inhibition Studies , 2016, Molecules.

[15]  S. Benbadis,et al.  Carbamazepine-related antiepileptic drugs for the treatment of epilepsy - a comparative review , 2016, Expert opinion on pharmacotherapy.

[16]  A. Szűcs,et al.  Epileptic Seizures in Alzheimer Disease: A Review , 2016, Alzheimer disease and associated disorders.

[17]  L. Carmant,et al.  Seizures and epilepsy: an overview for neuroscientists. , 2015, Cold Spring Harbor perspectives in medicine.

[18]  S. Strittmatter,et al.  Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model , 2015, Alzheimer's Research & Therapy.

[19]  Usman Ali Rana,et al.  Palladium (0) catalyzed Suzuki cross-coupling reactions of 2,4-dibromothiophene: selectivity, characterization and biological applications , 2015 .

[20]  Usman Ali Rana,et al.  Selective C-Arylation of 2,5-Dibromo-3-hexylthiophene via Suzuki Cross Coupling Reaction and Their Pharmacological Aspects , 2015, Molecules.

[21]  A. Zaitsev,et al.  N‐methyl‐D‐aspartate receptor channel blockers prevent pentylenetetrazole‐induced convulsions and morphological changes in rat brain neurons , 2015, Journal of neuroscience research.

[22]  Rammohan Sankaraneni,et al.  Antiepileptic drugs--a review. , 2015, Pediatric annals.

[23]  K. Chopra,et al.  Memantine delayed N‐methyl‐D‐aspartate ‐induced convulsions in neonatal rats , 2015, Fundamental & clinical pharmacology.

[24]  R. Goel,et al.  Adjuvant Anticholinesterase Therapy for the Management of Epilepsy‐Induced Memory Deficit: A Critical Pre‐clinical Study , 2014, Basic & clinical pharmacology & toxicology.

[25]  Xingrong Liu,et al.  Rational use of plasma protein and tissue binding data in drug design. , 2014, Journal of medicinal chemistry.

[26]  A. R. Aricescu,et al.  Crystal structure of a human GABAA receptor , 2014, Nature.

[27]  Haibin Liu,et al.  AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research , 2014, J. Chem. Inf. Model..

[28]  A. Shafiee,et al.  Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. , 2013, European journal of medicinal chemistry.

[29]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[30]  D. C. Medeiros,et al.  Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats , 2013, Epilepsy Research.

[31]  C. Sotriffer,et al.  Structure-Based Search for New Inhibitors of Cholinesterases , 2013, International journal of molecular sciences.

[32]  P. Feliciano.  Antiepileptic drugs in Alzheimer's , 2012, Nature Genetics.

[33]  Keith A. Vossel,et al.  Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model , 2012, Proceedings of the National Academy of Sciences.

[34]  M. Bialer.  Chemical properties of antiepileptic drugs (AEDs). , 2012, Advanced drug delivery reviews.

[35]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[36]  Daniel Friedman,et al.  Seizures and Epilepsy in Alzheimer's Disease , 2012, CNS neuroscience & therapeutics.

[37]  D. Abdallah.  Anticonvulsant potential of the peroxisome proliferator-activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice , 2010, Brain Research.

[38]  A. Mikulecká,et al.  Different effects of two N-methyl-d-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats , 2009, Epilepsy & Behavior.

[39]  Hualiang Jiang,et al.  Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics. , 2008, Biophysical journal.

[40]  Yvain Nicolet,et al.  Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products* , 2003, Journal of Biological Chemistry.

[41]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.

[42]  T. Uzbay,et al.  l-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice , 1997, Brain Research.

[43]  Anuradha,et al.  Epilepsy: A Comprehensive Review , 2019, Indo Global Journal of Pharmaceutical Sciences.

[44]  Emiliano Santarnecchi,et al.  Levetiracetam Alters Oscillatory Connectivity in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[45]  M. Msall,et al.  Medically complex children and early intervention for comprehensive medical care at home. , 2015, Pediatric annals.

[46]  Umer Ansari.  Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality , 2014 .